Lb Pharmaceuticals (LBRX) Return on Capital Employed (2025 - 2026)
Lb Pharmaceuticals (LBRX) recorded quarterly Return on Capital Employed of 11.51% in Q1 2026, down 40.14% quarter-over-quarter from 8.21% in Q4 2025.
Lb Pharmaceuticals (LBRX) Return on Capital Employed (2025 - 2026) Analysis & Trends
Lb Pharmaceuticals' Return on Capital Employed history runs 2 years deep, the most recent figure standing at 11.51% for Q1 2026.
- In Q1 2026, Return on Capital Employed changed N/A year-over-year to 11.51%; the TTM figure through Mar 2026 stood at 11.51% (changed N/A YoY), while the FY2025 annual figure was 15.2%, changed N/A from the prior year.
- Return on Capital Employed was 11.51% for Q1 2026 at Lb Pharmaceuticals, down from 8.21% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 8.21% in Q4 2025 to a low of 11.51% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Lb Pharmaceuticals | 843.30 Mn | 843.30 Mn | - | -11.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.51% |
| Dec 31, 2025 | -8.21% |